|
While most physicians are aware that drug companies collect
some information about which medications they prescribe, most
do not realize how detailed the information actually is.
Drug makers spend millions of dollars to develop secret reports
about doctors and their patients, including information such
as whether a patient is switched over to a competitor’s
drug and whether the doctor treats many poor patients and
may want free samples.
Pharmaceutical companies spent $19 billion on marketing in
2001, and $16 billion of it was spent on marketing to doctors.
Many doctors are seeing fewer drug sales representatives
and limiting their visits when they do, so the reports, or
"prescriber profiles," allow sales reps to tailor
their pitches to individual physicians.
The profiles allow sales reps to see a doctor’s prescribing
habits within days of when the prescription is written, which
allows them to see whether a doctor is responding to their
pitch. For instance, if a doctor prescribes a competitor’s
drug, the rep can focus the pitch on undermining that drug.
Further, drug companies would give gifts and trips to doctors
who routinely prescribed their drugs. There are now voluntary
industry guidelines in place that discourage such gifts.
Drug companies have been hiring outside firms to purchase
data on doctors from pharmacies since the mid-1990s. While
the practice is legal in the United States as long as patient
names are not revealed, it was outlawed in the Canadian province
of British Columbia in 1996.
Many doctors are concerned that the reports allow sales reps
to push expensive drugs more effectively in a health care
system that is already struggling with increasing costs. However,
according to one company that sells prescription data to drug
companies, the reports are used to promote safety and can
be used to monitor cases in which large groups of patients
are taking drugs that could have dangerous interactions.
Boston
Globe May 25, 2003 page A1
|